Honored to contribute to this new 3-part series on CVD in pregnancy @TheLancet. A massive thank you to @GarimaVSharmaMD and our incredible expert co-authors for the privilege to collaborate, create, & learn alongside you throughout this process.
https://t.co/nCxivpbYHB
Congratulations to the 2026 HFSA Award recipients! 🏆
We're proud to recognize the individuals and teams whose leadership, innovation, research, mentorship & service are advancing heart failure care.
Meet the honorees being recognized at #HFSA2026: https://t.co/YZwqyDwuau
Endlessly proud of #HFC member Dr. Vanessa Blumer on receiving the 2026 HFSA Rising Star Award! 💙
Congratulations on this well-deserved recognition! @ISHVnews@coconnormd@vbluml
The Stories Behind the People starts with @DrCaliff_FDA 🎙️
He joins Dr. Christopher O’Connor to explore the journey, values, defining moments, and experiences that shaped his remarkable career.
Tune in now https://t.co/xr2XTBjorf
Sharing our Perspective on why “not a candidate” should never become a verdict in advanced HF. Advanced therapy ineligibility is not synonymous with futility. Candidacy should be one data point, not the final verdict. @vbluml@ShashankSinhaMD
https://t.co/CRE7jSt1iC
Now in @JCardFail from #HFC members.
How does geography influence enrollment in HF clinical trials? This study examines regional variation in the enrollment of women, Black, Hispanic, and older adults across GUIDE-IT and HF-ACTION.
https://t.co/QtamVtJg9Q
Can we apply a class effect to cardiovascular devices the same way we do for drugs?
Our Heart of the Matter Cardio Pod tackles this timely question with an expert panel discussing evidence, regulatory considerations, and real-world implications.
🎧 https://t.co/Wp8VzIJSKd
Happy Birthday to #HFC member @vbluml!
You inspire so many through your roles as a mentor, physician, and leader. Thank you for your impactful contributions to the heart failure community.
Wishing you a wonderful year ahead filled with continued success and joy 💙🎉
#HFC members are at ESC HF 2026 in Barcelona 🇪🇸
Kicking off tomorrow with key discussions in heart failure.
Check out our members’ agenda for May 9 👇 #ESCHeartFailure2026#HFA2026
Thrilled to share the evidence for exercise in patients with cancer and move towards translating these findings into meaningful & personalized patient care. Grateful for the incredible teamwork at @ISHVnews@InovaHealth@AnaBaracCardio & to @AJPCardio to share our work
Happy to share our work on epicardial adipose tissue and exercise hemodynamics in HFpEF in @JCFINT 🚀
We used cMRI ➕ invasive hemodynamics ➕ upright exercise to understand the effect of EAT in patients with obesity and HFpEF
https://t.co/20faUzp6Uf
@DenWakeham@BrazileTiffany
Now in @JACCJournals – a cardiogenic shock survivorship continuum led by #HFC members @vbluml
This work proposes a novel three-phase framework, spanning acute stabilization, in-hospital assessment and optimization, and postdischarge care.
https://t.co/VB6kYgLqGk
Excited to share our latest from @masala_study in @JACCJournals
Parity & ASCVD risk in South Asian🤰🏻
👶 ≥2 births → 📈 ↑ BP & LDL-C (~5 yrs)
🫀Multiparity = ↑ CV risk signal → closer follow-up
Grateful to @jaideeppatelmd@GarimaVSharmaMD
https://t.co/ShtQHjjzLs
Pleased to share our publication on the safety of LLMs when answering patient-posed medical questions & why caution is still needed. A step toward responsible AI in healthcare.
@racheldraelos@InovaCVfellows@ISHVnews#Patientsafety#HealthcareAI
https://t.co/DShOhKR6Qi
Don’t miss our latest ACC piece on heart failure and why prevention is our greatest opportunity.
Focus on Heart Failure | A Long Road With Many Opportunities For Prevention - American College of Cardiology https://t.co/odEXe63Zsl
@vbluml@Chguilliod